WVE: Wave Life Sciences Ltd. Stock

by  •  • Comments Off on WVE: Wave Life Sciences Ltd. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,032.96
Enterprise Value ($M) 738.76
Book Value ($M) 217.39
Book Value / Share 1.42
Price / Book 4.75
NCAV ($M) 185.58
NCAV / Share 1.21
Price / NCAV 5.57

Profitability (mra)
Return on Invested Capital (ROIC) -0.40
Return on Assets (ROA) -0.41
Return on Equity (ROE) -2.92

Liquidity (mrq)
Quick Ratio 2.89
Current Ratio 2.89

Balance Sheet (mrq) ($M)
Current Assets 320.39
Assets 352.21
Liabilities 134.82
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 108.30
Operating Income -110.40
Net Income -97.01
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -151.03
Cash from Investing -0.94
Cash from Financing 253.89

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Maverick Capital Ltd 5.40 -2.21
02-05 13G/A BlackRock, Inc. 6.10 28.25
11-12 13G/A Adage Capital Management, L.P. 6.66
11-12 13G/A M28 Capital Management LP 4.20 -16.39
11-12 13G/A Glaxosmithkline Plc 11.20 19.97
10-01 13D/A Ra Capital Management, L.p. 16.00 47.16

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-04-29 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)
2025-03-04 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-29 440,081 1,497,961 29.38
2025-04-28 254,243 864,943 29.39
2025-04-25 226,394 666,755 33.95
2025-04-24 395,963 1,098,115 36.06
2025-04-23 472,192 1,783,634 26.47

(click for more detail)

Similar Companies
VERA – Vera Therapeutics, Inc. VNDA – Vanda Pharmaceuticals Inc.
VRCA – Verrica Pharmaceuticals Inc. XENE – Xenon Pharmaceuticals Inc.
XNCR – Xencor, Inc.


Financial data and stock pages provided by
Fintel.io